Half-year report · Q2
4465.TEDINET S100V2OA
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.7bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥22.7bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.2bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Operating income | ¥879m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Operating income | ¥631m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Ordinary income | ¥906m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥625m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥906m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Profit before tax | −¥53m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥608m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥706m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥120m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥608m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Net income | ¥124m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Total assets | ¥23.3bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥22.7bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.5bn | at 2024-11-30 | Cons. | Liabilities |
| Total liabilities | ¥9.4bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.8bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥13.4bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.0bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.3bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.9bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥310m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥449m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥358m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥102m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥270m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥425m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥603m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥103.03 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥119.58 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.37 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.4% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.7% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥11.0bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥11.0bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥731m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥671m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥671m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥148m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥11.7bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥11.7bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥879m |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥10.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥10.5bn |
| jpcrp040300-q2r_E00890-000Chemical Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥579m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥693m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥693m |
| jpcrp040300-q2r_E00890-000Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥52m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥11.2bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥11.2bn |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥631m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | Prior1YTDDuration | 1920000 | JPY |
| Other net inv cf | CurrentYTDDuration | -3358000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 269607000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -357537000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -406890000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -288593000 | JPY |
| Redemption of bonds fin cf | Prior1YTDDuration | -5000000 | JPY |
| Redemption of bonds fin cf | CurrentYTDDuration | -5000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -188910000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -129875000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -2016000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -1956000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -602816000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -425425000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 45997000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -12839000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 162269000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -486269000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6745342000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6832763000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 6907612000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 6346493000 | JPY |
| Employees salaries and bonuses sga | Prior1YTDDuration | 867277000 | JPY |
| Employees salaries and bonuses sga | CurrentYTDDuration | 880343000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 49442000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 49078000 | JPY |
| Freightage expenses sga | Prior1YTDDuration | 751500000 | JPY |
| Freightage expenses sga | CurrentYTDDuration | 777409000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 10534760000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 693239000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 11228000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 11228000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 10534760000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 693239000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 11228000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 11228000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 578906000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 51931000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 630837000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 630837000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00890-000ChemicalBusinessReportableSegmentsMember | 11019601000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00890-000HealthcareBusinessReportableSegmentsMember | 671474000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |